The latest closing stock price for Nautilus Biotechnology as of September 18, 2024 is 2.87.
An investor who bought $1,000 worth of Nautilus Biotechnology stock at the IPO in 2021 would have $-695 today, roughly -1 times their original investment - a -32.69% compound annual growth rate over 3 years.
The all-time high Nautilus Biotechnology stock closing price was 10.10 on June 30, 2021.
The Nautilus Biotechnology 52-week high stock price is 3.49, which is 21.6% above the current share price.
The Nautilus Biotechnology 52-week low stock price is 2.19, which is 23.7% below the current share price.
The average Nautilus Biotechnology stock price for the last 52 weeks is 2.73.
An investor who bought $1,000 worth of Nautilus Biotechnology stock at the IPO in 2021 would have $-695 today, roughly -1 times their original investment - a -32.69% compound annual growth rate over 3 years.
The all-time high Nautilus Biotechnology stock closing price was 10.10 on June 30, 2021.
The Nautilus Biotechnology 52-week high stock price is 3.49, which is 21.6% above the current share price.
The Nautilus Biotechnology 52-week low stock price is 2.19, which is 23.7% below the current share price.
The average Nautilus Biotechnology stock price for the last 52 weeks is 2.73.